blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP4218801

EP4218801 - ANTIBODY MODIFICATION METHOD FOR PURIFYING BISPECIFIC ANTIBODY [Right-click to bookmark this link]
StatusExamination is in progress
Status updated on  19.04.2024
Database last updated on 25.09.2024
FormerRequest for examination was made
Status updated on  23.02.2024
FormerThe application has been published
Status updated on  30.06.2023
Most recent event   Tooltip14.08.2024New entry: Despatch of examination report + time limit 
Applicant(s)For all designated states
Chugai Seiyaku Kabushiki Kaisha
5-1, Ukima 5-chome Kita-ku
Tokyo 115-8543 / JP
[2023/31]
Inventor(s)01 / IGAWA, Tomoyuki
Shizuoka, 412-8513 / JP
02 / TSUNODA, Hiroyuki
Shizuoka, 412-8513 / JP
 [2023/31]
Representative(s)Vossius & Partner Patentanwälte Rechtsanwälte mbB
Siebertstraße 3
81675 München / DE
[2023/31]
Application number, filing date23150077.830.03.2007
[2023/31]
Priority number, dateJP2006009779531.03.2006         Original published format: JP 2006097795
JP2006027580406.10.2006         Original published format: JP 2006275804
[2023/31]
Filing languageEN
Procedural languageEN
PublicationType: A2 Application without search report 
No.:EP4218801
Date:02.08.2023
Language:EN
[2023/31]
Type: A3 Search report 
No.:EP4218801
Date:23.08.2023
Language:EN
[2023/34]
Search report(s)(Supplementary) European search report - dispatched on:EP26.07.2023
ClassificationIPC:A61K39/00, A61P43/00, C07K16/00, C07K19/00, C12N1/15, C12N1/19, C12N1/21, C12N15/09, C12N5/10, C12P21/02
[2023/31]
CPC:
C07K16/00 (EP,US); A61P35/00 (EP); A61P37/00 (EP);
A61P43/00 (EP); C07K16/248 (EP,US); C07K2317/24 (EP,US);
C07K2317/31 (EP,US); C07K2317/522 (EP,US); C07K2317/524 (EP,US);
C07K2317/526 (EP,US); C07K2317/56 (EP,US); C07K2317/567 (EP,US);
C07K2317/76 (EP,US) (-)
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MT,   NL,   PL,   PT,   RO,   SE,   SI,   SK,   TR [2024/13]
Former [2023/31]AT,  BE,  BG,  CH,  CY,  CZ,  DE,  DK,  EE,  ES,  FI,  FR,  GB,  GR,  HU,  IE,  IS,  IT,  LI,  LT,  LU,  LV,  MC,  MT,  NL,  PL,  PT,  RO,  SE,  SI,  SK,  TR 
TitleGerman:ANTIKÖRPERMODIFIZIERUNGSVERFAHREN ZUR REINIGUNG EINES BISPEZIFISCHEN ANTIKÖRPERS[2023/31]
English:ANTIBODY MODIFICATION METHOD FOR PURIFYING BISPECIFIC ANTIBODY[2023/31]
French:PROCÉDÉ DE MODIFICATION D'ANTICORPS POUR PURIFIER UN ANTICORPS BISPÉCIFIQUE[2023/31]
Examination procedure16.02.2024Amendment by applicant (claims and/or description)
16.02.2024Examination requested  [2024/13]
16.02.2024Date on which the examining division has become responsible
23.04.2024Despatch of a communication from the examining division (Time limit: M04)
05.08.2024Reply to a communication from the examining division
13.08.2024Despatch of a communication from the examining division (Time limit: M04)
Parent application(s)   TooltipEP07740494.5  / EP2009101
EP17196942.1  / EP3345616
Fees paidRenewal fee
01.02.2023Renewal fee patent year 03
01.02.2023Renewal fee patent year 04
01.02.2023Renewal fee patent year 05
01.02.2023Renewal fee patent year 06
01.02.2023Renewal fee patent year 07
01.02.2023Renewal fee patent year 08
01.02.2023Renewal fee patent year 09
01.02.2023Renewal fee patent year 10
01.02.2023Renewal fee patent year 11
01.02.2023Renewal fee patent year 12
01.02.2023Renewal fee patent year 13
01.02.2023Renewal fee patent year 14
01.02.2023Renewal fee patent year 15
01.02.2023Renewal fee patent year 16
01.02.2023Renewal fee patent year 17
14.03.2024Renewal fee patent year 18
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search[E]EP1870459  (CHUGAI PHARMACEUTICAL CO LTD [JP]);
by applicantJPH02504970
 EP0125023
 EP0239400
 JPH0159878B
 EP0404097
 WO9201047
 WO9203918
 WO9219759
 WO9220791
 WO9306213
 WO9311161
 WO9311236
 WO9312227
 WO9319172
 WO9402602
 WO9501438
 WO9515393
 WO9515388
 WO9602576
 WO9634096
 WO9633735
 WO9813388
 WO9846777
 WO9951743
 JP2005112514
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.